High FSH : LH ratio and low LH levels in basal cycle day 3: Impact on follicular development and IVF outcome

Citation
G. Barroso et al., High FSH : LH ratio and low LH levels in basal cycle day 3: Impact on follicular development and IVF outcome, J AS REPROD, 18(9), 2001, pp. 499-505
Citations number
24
Categorie Soggetti
Reproductive Medicine
Journal title
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
ISSN journal
10580468 → ACNP
Volume
18
Issue
9
Year of publication
2001
Pages
499 - 505
Database
ISI
SICI code
1058-0468(200109)18:9<499:HF:LRA>2.0.ZU;2-S
Abstract
Purpose. To examine the impact of low basal cycle day 3 serum LH levels or a high FSH.-LH ratio on IVF results. Methods. A homogeneous group of patients was analyzed as identified by norm al basal cycle of follicle stimulating hormone (FSH), Luteinizing hormone ( LH), and estradiol (E-2) levels. High responders (high LH:FSH ratio) and lo w responders (high FSH or E2 levels, and women greater than or equal to 42 years of age) were excluded from analysis. Only cycles stimulated with a co mbination of a GnRHa (luteal suppression) and pure FSH were studied. Results. Patients with low basal LH levels (<3 mIU/mL) did not differ signi ficantly from controls in terms of response to controlled ovarian hyperstim ulation but there was a clear trend toward poorer implantation and clinical pregnancy rates. On the other hand, patients with a high FSH.-LH ratio (>3 ) had significantly fewer mature oocytes aspirated, and lower implantation and clinical pregnancy rates than patients with gonadotropin ratio <3. Thes e negative effects were evident in the presence of normal basal FSH levels and after adequate matching of female's age and number of embryos transferr ed. Conclusions. These studies highlight a negative impact of a basal cycle hig h FSH.-LH ratio (and possibly low LH levels) on follicular development and oocyte quality in these patients subjected to pituitary down-regulation fol lowed by pure FSH administration. A high FSH.-LH ratio may be therefore use d as an early biomarker of poor ovarian response.